Qscription Technologies Appoints Anurag Velekkatt Sunil Kumar to Drive Enterprise Scale
By:
PRLog
June 16, 2026 at 19:55 PM EDT
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
WEST BEND, Wis. - June 16, 2026 - PRLog -- Qscription Technologies, a specialized business-to-business healthcare technology infrastructure provider, today announced the formal appointment of Anurag Velekkatt Sunil Kumar to the dual role of Project Manager and Vice President (VP) of MedTech Operations. In this executive capacity, Mr. Velekkatt will report directly to the Company's Board of Directors, assuming total operational command and strategic governance over the technical planning, resource allocation, and clinical deployment of the company's enterprise integration pipelines across the United States.
Qscription Technologies provides a secure, middle-layer data orchestration platform designed to accelerate the deployment of Software as a Medical Device (SaMD) and clinical artificial intelligence applications into traditional hospital IT systems, Picture Archiving and Communication Systems (PACS), and diagnostic networks. By standardizing secure data routing, the company reduces enterprise integration timelines from 18 months to under 30 days.
As VP of MedTech Operations, Mr. Velekkatt will direct Qscription's core engineering delivery division. His responsibilities include formulating technical deployment frameworks, managing cross-functional software engineering sprint cycles, and auditing multi-vendor integration standards to guarantee absolute compliance with HIPAA Security Rules and FDA quality systems regulations. He will serve as the principal technical interface between Qscription's internal assets and executive stakeholders across client hospital networks.
Mr. Velekkatt joins Qscription Technologies with a highly distinguished engineering and project steering pedigree within the medical imaging space. He previously served as a Senior Technical Engineer at GE HealthCare, where he engineered complex data architectures, managed PACS network boundaries, and steered large-scale international clinical deployments. He holds a technical degree in engineering, providing the deep academic and practical foundation required to navigate high-security healthcare IT ecosystems and direct complex software lifecycles.
"The Board of Directors is incredibly proud to appoint Anurag to lead our operational infrastructure," said Ajeesh Kumar, Founder and Majority Shareholder of Qscription Technologies. "As we accelerate our enterprise integration pipelines with major market partners like Xpertiz and deepc, Anurag's executive vision and deep domain expertise with institutional imaging networks make him uniquely qualified to command our technical rollouts, safeguard data integrity, and enforce rigid SLA compliance at scale."
Under Mr. Velekkatt's leadership, Qscription's MedTech division will focus its immediate operational roadmap on deploying upcoming mid-tier regional hospital pilots, ensuring seamless, high-throughput handshakes between physical diagnostic hardware and advanced cloud-based diagnostic platforms.
https://qscription.tech
Photos: (Click photo to enlarge)
Source: Qscription Technologies
Read Full Story - Qscription Technologies Appoints Anurag Velekkatt Sunil Kumar to Drive Enterprise Scale | More news from this source
Press release distribution by PRLog
Report this content
If you believe this article contains misleading, harmful, or spam content, please let us know.
Report this articleMore News
View More
As Stablecoins Keep Growing, These 2 Stocks Benefit ↗
Today 11:35 EDT
Costco’s Secret Growth Engine May Be Running Out of Gas ↗
Today 9:50 EDT
Why Alphabet’s Pullback May Be an Opportunity in Disguise ↗
Today 8:55 EDT
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>